 | • レポートコード：QYR9ST01719 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の精神分裂病治療薬市場について調査・分析し、以下の構成でお届け致します。精神分裂病治療薬の種類別には、経口抗精神病薬、注射用抗精神病薬に、用途別には、病院、クリニックに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別精神分裂病治療薬売上データ ・地域別精神分裂病治療薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別精神分裂病治療薬市場規模：経口抗精神病薬、注射用抗精神病薬 ・用途別精神分裂病治療薬市場規模：病院、クリニック ・主要メーカーの企業情報：Johnson & Johnson、Bristol-Myers Squibb、Otsuka Pharma、AstraZeneca、Sumitomo Dainippon、Eli Lilly、Alkermes、Vanda Pharma、Allergan、Pfizer ・精神分裂病治療薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Schizophrenia is a mental disorder characterized by abnormal social behavior and failure to understand reality. Common symptoms include false beliefs, unclear or confused thinking, hearing voices that others do not, reduced social engagement and emotional expression, and a lack of motivation.The global Schizophrenia Drugs market is valued at 5310 million US$ in 2018 and will reach 6470 million US$ by the end of 2025, growing at a CAGR of 2.5% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Schizophrenia Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Schizophrenia Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Schizophrenia Drugs in these regions.
This research report categorizes the global Schizophrenia Drugs market by top players/brands, region, type and end user. This report also studies the global Schizophrenia Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Johnson & Johnson
Bristol-Myers Squibb
Otsuka Pharma
AstraZeneca
Sumitomo Dainippon
Eli Lilly
Alkermes
Vanda Pharma
Allergan
Pfizer
Market size by Product
Oral Antipsychotics
Injectable Antipsychotics
Market size by End User
Hospital
Clinic
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Schizophrenia Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Schizophrenia Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Schizophrenia Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Schizophrenia Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Schizophrenia Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Schizophrenia Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Schizophrenia Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Schizophrenia Drugs Market Size Growth Rate by Product
1.4.2 Oral Antipsychotics
1.4.3 Injectable Antipsychotics
1.5 Market by End User
1.5.1 Global Schizophrenia Drugs Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Schizophrenia Drugs Market Size
2.1.1 Global Schizophrenia Drugs Revenue 2014-2025
2.1.2 Global Schizophrenia Drugs Sales 2014-2025
2.2 Schizophrenia Drugs Growth Rate by Regions
2.2.1 Global Schizophrenia Drugs Sales by Regions
2.2.2 Global Schizophrenia Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Schizophrenia Drugs Sales by Manufacturers
3.1.1 Schizophrenia Drugs Sales by Manufacturers
3.1.2 Schizophrenia Drugs Sales Market Share by Manufacturers
3.1.3 Global Schizophrenia Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Schizophrenia Drugs Revenue by Manufacturers
3.2.1 Schizophrenia Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Schizophrenia Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Schizophrenia Drugs Price by Manufacturers
3.4 Schizophrenia Drugs Manufacturing Base Distribution, Product Types
3.4.1 Schizophrenia Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Schizophrenia Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Schizophrenia Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Schizophrenia Drugs Sales by Product
4.2 Global Schizophrenia Drugs Revenue by Product
4.3 Schizophrenia Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Schizophrenia Drugs Breakdown Data by End User
6 North America
6.1 North America Schizophrenia Drugs by Countries
6.1.1 North America Schizophrenia Drugs Sales by Countries
6.1.2 North America Schizophrenia Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Schizophrenia Drugs by Product
6.3 North America Schizophrenia Drugs by End User
7 Europe
7.1 Europe Schizophrenia Drugs by Countries
7.1.1 Europe Schizophrenia Drugs Sales by Countries
7.1.2 Europe Schizophrenia Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Schizophrenia Drugs by Product
7.3 Europe Schizophrenia Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Schizophrenia Drugs by Countries
8.1.1 Asia Pacific Schizophrenia Drugs Sales by Countries
8.1.2 Asia Pacific Schizophrenia Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Schizophrenia Drugs by Product
8.3 Asia Pacific Schizophrenia Drugs by End User
9 Central & South America
9.1 Central & South America Schizophrenia Drugs by Countries
9.1.1 Central & South America Schizophrenia Drugs Sales by Countries
9.1.2 Central & South America Schizophrenia Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Schizophrenia Drugs by Product
9.3 Central & South America Schizophrenia Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Schizophrenia Drugs by Countries
10.1.1 Middle East and Africa Schizophrenia Drugs Sales by Countries
10.1.2 Middle East and Africa Schizophrenia Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Schizophrenia Drugs by Product
10.3 Middle East and Africa Schizophrenia Drugs by End User
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Company Business Overview
11.1.3 Johnson & Johnson Schizophrenia Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Johnson & Johnson Schizophrenia Drugs Products Offered
11.1.5 Johnson & Johnson Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Company Business Overview
11.2.3 Bristol-Myers Squibb Schizophrenia Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Bristol-Myers Squibb Schizophrenia Drugs Products Offered
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Otsuka Pharma
11.3.1 Otsuka Pharma Company Details
11.3.2 Company Business Overview
11.3.3 Otsuka Pharma Schizophrenia Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Otsuka Pharma Schizophrenia Drugs Products Offered
11.3.5 Otsuka Pharma Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 Company Business Overview
11.4.3 AstraZeneca Schizophrenia Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 AstraZeneca Schizophrenia Drugs Products Offered
11.4.5 AstraZeneca Recent Development
11.5 Sumitomo Dainippon
11.5.1 Sumitomo Dainippon Company Details
11.5.2 Company Business Overview
11.5.3 Sumitomo Dainippon Schizophrenia Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Sumitomo Dainippon Schizophrenia Drugs Products Offered
11.5.5 Sumitomo Dainippon Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Company Business Overview
11.6.3 Eli Lilly Schizophrenia Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Eli Lilly Schizophrenia Drugs Products Offered
11.6.5 Eli Lilly Recent Development
11.7 Alkermes
11.7.1 Alkermes Company Details
11.7.2 Company Business Overview
11.7.3 Alkermes Schizophrenia Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Alkermes Schizophrenia Drugs Products Offered
11.7.5 Alkermes Recent Development
11.8 Vanda Pharma
11.8.1 Vanda Pharma Company Details
11.8.2 Company Business Overview
11.8.3 Vanda Pharma Schizophrenia Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Vanda Pharma Schizophrenia Drugs Products Offered
11.8.5 Vanda Pharma Recent Development
11.9 Allergan
11.9.1 Allergan Company Details
11.9.2 Company Business Overview
11.9.3 Allergan Schizophrenia Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Allergan Schizophrenia Drugs Products Offered
11.9.5 Allergan Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Company Business Overview
11.10.3 Pfizer Schizophrenia Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Pfizer Schizophrenia Drugs Products Offered
11.10.5 Pfizer Recent Development
12 Future Forecast
12.1 Schizophrenia Drugs Market Forecast by Regions
12.1.1 Global Schizophrenia Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Schizophrenia Drugs Revenue Forecast by Regions 2019-2025
12.2 Schizophrenia Drugs Market Forecast by Product
12.2.1 Global Schizophrenia Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Schizophrenia Drugs Revenue Forecast by Product 2019-2025
12.3 Schizophrenia Drugs Market Forecast by End User
12.4 North America Schizophrenia Drugs Forecast
12.5 Europe Schizophrenia Drugs Forecast
12.6 Asia Pacific Schizophrenia Drugs Forecast
12.7 Central & South America Schizophrenia Drugs Forecast
12.8 Middle East and Africa Schizophrenia Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Schizophrenia Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Schizophrenia Drugs Product Picture
Table Schizophrenia Drugs Market Segments
Table Key Manufacturers Schizophrenia Drugs Covered
Table Global Schizophrenia Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Schizophrenia Drugs Sales Market Share by Product 2014-2025
Figure Oral Antipsychotics Product Picture
Table Major Manufacturers of Oral Antipsychotics
Figure Injectable Antipsychotics Product Picture
Table Major Manufacturers of Injectable Antipsychotics
Table Global Schizophrenia Drugs Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospital
Figure Clinic
Figure Schizophrenia Drugs Report Years Considered
Figure Global Schizophrenia Drugs Market Size 2014-2025 (Million US$)
Figure Global Schizophrenia Drugs Sales 2014-2025 (K Units)
Table Global Schizophrenia Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Schizophrenia Drugs Sales by Regions 2014-2019 (K Units)
Table Global Schizophrenia Drugs Sales Market Share by Regions 2014-2019
Figure Global Schizophrenia Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Schizophrenia Drugs Sales Market Share by Regions
Table Global Schizophrenia Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Schizophrenia Drugs Revenue Market Share by Regions 2014-2019
Figure Global Schizophrenia Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Schizophrenia Drugs Revenue Market Share by Regions
Table Global Schizophrenia Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Schizophrenia Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Schizophrenia Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Schizophrenia Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Schizophrenia Drugs Revenue Share by Manufacturers (2014-2019)
Figure Schizophrenia Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Schizophrenia Drugs Price (2014-2019) (USD/Unit)
Table Schizophrenia Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Schizophrenia Drugs Product Type
Table Date of International Manufacturers Enter into Schizophrenia Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Schizophrenia Drugs Sales by Product (2014-2019) (K Units)
Table Global Schizophrenia Drugs Sales Share by Product (2014-2019)
Figure Global Schizophrenia Drugs Sales Market Share by Product (2014-2019)
Figure Global Schizophrenia Drugs Sales Market Share by Product in 2018
Table Global Schizophrenia Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Schizophrenia Drugs Revenue Share by Product (2014-2019)
Figure Global Schizophrenia Drugs Revenue Market Share by Product (2014-2019)
Figure Global Schizophrenia Drugs Revenue Market Share by Product in 2018
Table Schizophrenia Drugs Price by Product 2014-2019 (USD/Unit)
Table Global Schizophrenia Drugs Sales by End User (2014-2019) (K Units)
Table Global Schizophrenia Drugs Sales Share by End User (2014-2019)
Figure Global Sales Schizophrenia Drugs Market Share by End User (2014-2019)
Figure Global Sales Schizophrenia Drugs Market Share by End User in 2018
Figure North America Schizophrenia Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America Schizophrenia Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Schizophrenia Drugs Sales by Countries (2014-2019) (K Units)
Table North America Schizophrenia Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Schizophrenia Drugs Sales Market Share by Countries
Table North America Schizophrenia Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Schizophrenia Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Schizophrenia Drugs Revenue Market Share by Countries
Figure United States Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure United States Schizophrenia Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada Schizophrenia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Schizophrenia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Schizophrenia Drugs Sales by Product (2014-2019) (K Units)
Table North America Schizophrenia Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Schizophrenia Drugs Market Share by Product
Table North America Schizophrenia Drugs Sales by End User (2014-2019) (K Units)
Table North America Schizophrenia Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Schizophrenia Drugs Market Share by End User
Figure Europe Schizophrenia Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe Schizophrenia Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Schizophrenia Drugs Sales by Countries (2014-2019) (K Units)
Table Europe Schizophrenia Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Schizophrenia Drugs Sales Market Share by Countries
Table Europe Schizophrenia Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Schizophrenia Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Schizophrenia Drugs Revenue Market Share by Countries
Figure Germany Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Germany Schizophrenia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France Schizophrenia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK Schizophrenia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy Schizophrenia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia Schizophrenia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Schizophrenia Drugs Sales by Product (2014-2019) (K Units)
Table Europe Schizophrenia Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Schizophrenia Drugs Market Share by Product
Table Europe Schizophrenia Drugs Sales by End User (2014-2019) (K Units)
Table Europe Schizophrenia Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Schizophrenia Drugs Market Share by End User
Figure Asia Pacific Schizophrenia Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Schizophrenia Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Schizophrenia Drugs Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Schizophrenia Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Schizophrenia Drugs Sales Market Share by Countries
Table Asia Pacific Schizophrenia Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Schizophrenia Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Schizophrenia Drugs Revenue Market Share by Countries
Figure China Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China Schizophrenia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Schizophrenia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Schizophrenia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Schizophrenia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia Schizophrenia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Schizophrenia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Schizophrenia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Schizophrenia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Schizophrenia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Schizophrenia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Schizophrenia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Schizophrenia Drugs Sales by Product (2014-2019) (K Units)
Table Asia Pacific Schizophrenia Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Schizophrenia Drugs Market Share by Product
Table Asia Pacific Schizophrenia Drugs Sales by End User (2014-2019) (K Units)
Table Asia Pacific Schizophrenia Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Schizophrenia Drugs Market Share by End User
Figure Central & South America Schizophrenia Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Schizophrenia Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Schizophrenia Drugs Sales by Countries (2014-2019) (K Units)
Table Central & South America Schizophrenia Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Schizophrenia Drugs Sales Market Share by Countries
Table Central & South America Schizophrenia Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Schizophrenia Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Schizophrenia Drugs Revenue Market Share by Countries
Figure Brazil Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Schizophrenia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Schizophrenia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Schizophrenia Drugs Sales by Product (2014-2019) (K Units)
Table Central & South America Schizophrenia Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Schizophrenia Drugs Market Share by Product
Table Central & South America Schizophrenia Drugs Sales by End User (2014-2019) (K Units)
Table Central & South America Schizophrenia Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Schizophrenia Drugs Market Share by End User
Figure Middle East and Africa Schizophrenia Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Schizophrenia Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Schizophrenia Drugs Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Schizophrenia Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Schizophrenia Drugs Sales Market Share by Countries
Table Middle East and Africa Schizophrenia Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Schizophrenia Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Schizophrenia Drugs Revenue Market Share by Countries
Figure GCC Countries Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Schizophrenia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Schizophrenia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Schizophrenia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Schizophrenia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Schizophrenia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Schizophrenia Drugs Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Schizophrenia Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Schizophrenia Drugs Market Share by Product
Table Middle East and Africa Schizophrenia Drugs Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Schizophrenia Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Schizophrenia Drugs Market Share by End User
Table Johnson & Johnson Company Details
Table Johnson & Johnson Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Otsuka Pharma Company Details
Table Otsuka Pharma Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Otsuka Pharma Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Sumitomo Dainippon Company Details
Table Sumitomo Dainippon Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sumitomo Dainippon Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly Recent Development
Table Alkermes Company Details
Table Alkermes Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Alkermes Recent Development
Table Vanda Pharma Company Details
Table Vanda Pharma Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Vanda Pharma Recent Development
Table Allergan Company Details
Table Allergan Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Allergan Recent Development
Table Pfizer Company Details
Table Pfizer Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Global Schizophrenia Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Global Schizophrenia Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Schizophrenia Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Schizophrenia Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Schizophrenia Drugs Sales Forecast by Product 2019-2025 (K Units)
Table Global Schizophrenia Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Schizophrenia Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Schizophrenia Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Schizophrenia Drugs Sales Forecast by End User 2019-2025 (K Units)
Table Global Schizophrenia Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Schizophrenia Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Schizophrenia Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Schizophrenia Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Schizophrenia Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Schizophrenia Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Schizophrenia Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Schizophrenia Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Schizophrenia Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Schizophrenia Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Schizophrenia Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Schizophrenia Drugs Value Chain
Table Schizophrenia Drugs Customers List
Table Schizophrenia Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
精神分裂病治療法の世界市場：市場規模・現状・予測 Schizophrenia therapeutics are used as a standard treatment regimen for schizophrenia. It helps in reversing the low levels of dopamine and serotonin, thereby improving the patient's condition.The second-generation antipsychotic drugs segment accounted for the majority market shares because these dr…- 精神分裂病治療法の世界市場：市場規模・現状・予測 Schizophrenia therapeutics are used as a standard treatment regimen for schizophrenia. It helps in reversing the low levels of dopamine and serotonin, thereby improving the patient's condition.The second-generation antipsychotic drugs segment accounted for the majority market shares because these dr…
- 精神分裂病治療の世界市場：市場規模・現状・予測 Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality.The mainstay of schizophrenia treatment is antipsychotic medication, along with counselling, job training and social rehabilitation. In 2018, the global Schizophrenia Therapeutic market size was x…
- 精神分裂病治療の世界市場：市場規模・現状・予測 Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality.The mainstay of schizophrenia treatment is antipsychotic medication, along with counselling, job training and social rehabilitation. In 2018, the global Schizophrenia Therapeutic market size was x…
- 抗精神病薬の世界市場：インサイト・予測 Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder.During 2016, the second-generation antipsychotic dr…